Eastman Chemical (NYSE: EMN) reported Q3 EPS of $1.14, $0.02 worse than the analyst estimate of $1.16. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.26 billion.

GUIDANCE:

Eastman Chemical sees FY2025 EPS of $5.40-$5.65, versus the consensus of $5.77.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.